###begin article-title 0
###xml 64 69 <span type="species:ncbi:9606">human</span>
A novel E2 box-GATA element modulates Cdc6 transcription during human cells polyploidization
###end article-title 0
###begin p 1
###xml 93 110 93 110 <email xmlns:xlink="http://www.w3.org/1999/xlink">ccales@iib.uam.es</email>
To whom correspondence should be addressed. Tel: +34 91 5854469; Fax: +34 91 5854401; Email: ccales@iib.uam.es
###end p 1
###begin p 2
Present address: Nuria Vilaboa, Department of Experimental Surgery, Bone Metabolism Laboratory, Hospital 'La Paz', Madrid, Spain
###end p 2
###begin p 3
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 3
###begin p 4
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 396 428 396 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster escargot</italic>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 564 572 564 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escargot</italic>
###xml 687 691 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 828 831 828 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 907 915 907 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escargot</italic>
###xml 951 959 951 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1196 1203 1196 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1378 1381 1378 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1387 1392 1387 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 396 419 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Cdc6 is a key regulator of the strict alternation of S and M phases during the mitotic cell cycle. In mammalian and plant cells that physiologically become polyploid, cdc6 is transcriptionally and post-translationally regulated. We have recently reported that Cdc6 levels are maintained in megakaryoblastic HEL cells, but severely downregulated by ectopic expression of transcriptional repressor Drosophila melanogaster escargot. Here, we show that cdc6 promoter activity is upregulated during megakaryocytic differentiation of HEL endoreplicating cells, and that Escargot interferes with such activation. Transactivation experiments showed that a 1.7 kb region located at 2800 upstream cdc6 transcription initiation site behaved as a potent enhancer in endoreplicating cells only. This activity was mainly dependent on a novel cis-regulatory element composed by an E2 box overlapping a GATA motif. Ectopic Escargot could bind this regulatory element in vitro and endogenous GATA-1 and E2A formed specific complexes in megakaryoblastic cells as well as in primary megakaryocytes. Chromatin Immunoprecipitation analysis revealed that both transcription factors were occupying the E2 box/GATA site in vivo. Altogether, these data suggest that cdc6 expression could be actively maintained during megakaryocytic differentiation through transcriptional mechanisms involving specific cis- and trans-regulatory elements.
###end p 4
###begin title 5
INTRODUCTION
###end title 5
###begin p 6
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c1">1</xref>
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c2">2</xref>
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c3">3</xref>
###xml 480 481 480 481 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 580 581 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c4">4</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c7">7</xref>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snail</italic>
###xml 652 655 652 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sna</italic>
###xml 661 669 661 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escargot</italic>
###xml 671 674 671 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 714 715 714 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 818 819 818 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c8">8</xref>
###xml 900 910 900 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 918 919 918 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c9">9</xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c10">10</xref>
###xml 936 941 <span type="species:ncbi:10090">mouse</span>
Several terminally differentiated cell lineages, from plants to mammals, repeatedly enter S phase without completing mitosis in order to become polyploid (1,2). Among them, platelet precursors, megakaryocytes, undergo endoreplication in a process traditionally known as endomitosis. Megakaryocytic polyploidization is believed to be essential for full platelet production (3). As in other endoreplicating cells, megakaryocytic endomitosis is accompanied by a specific control of G1/S transition cell cycle machinery, which enables the establishment of such truncated cell cycles (4-7). We have also recently shown that transcriptional repressor Snail (Sna) and Escargot (Esg) interfere with the regulation of the G1/S transition of endomitotic cycles and therefore with polyploidization of megakaryoblastic HEL cells (8). These proteins also inhibit the entrance into endocycles of embryo and larval Drosophila cells (9), as well as of mouse trophoblast (10). However, little is known about the putative targets of these transcriptional repressors and how they are affecting the establishment of endomitosis.
###end p 6
###begin p 7
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 219 220 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c12">12</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c13">13</xref>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 610 621 610 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c14">14</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c15">15</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c15">15</xref>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 938 942 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 610 621 <span type="species:ncbi:3702">Arabidopsis</span>
We have recently described that Cdc6 is differentially regulated during megakaryocytic polyploidization (11). Cdc6 is one of the essential factors involved in assembling and licensing origins of replication during the G1 phase of the mitotic cell cycle [for a review see (12)]. Its expression and ability to load MCM complex onto the origin of replication are tightly regulated in the majority of somatic cells to ensure that DNA is replicated only once per cell cycle (13). Interestingly, cdc6 expression seems to be stabilized not only in megakaryoblastic cells that undergo endoreplication (11) but also in Arabidopsis endoreplicating cells (14,15). As also reported in plant cells (15), what we previously found was that the maintenance of cdc6 expression during megakaryocytic differentiation could be achieved through post-translational stabilization in cyclin E overexpressing cells, and also through transcriptional regulation of cdc6 gene (11).
###end p 7
###begin p 8
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c16">16</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c18">18</xref>
###xml 148 158 148 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c19">19</xref>
###xml 199 210 199 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c14">14</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c20">20</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c21">21</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c22">22</xref>
###xml 524 526 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c16">16</xref>
###xml 527 529 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c18">18</xref>
###xml 662 664 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c17">17</xref>
###xml 199 210 <span type="species:ncbi:3702">Arabidopsis</span>
Cdc6 expression peaks during G1 and is transcriptionally regulated in an E2F-, cell cycle-related manner, not only in mammalian (16-18) but also in Drosophila (19) and plant cells, as is the case of Arabidopsis (14,20). In mammalian cells, this control is mediated through E2F-2 and E2F-3 binding to specific sites proximal to the gene transcription initiation site (21,22). In fact, the essential regulatory region is contained within approximately300 bp of the 5' flanking region, where the E2F-binding sites are located (16-18), and no further proliferation-mediated transcriptional activity is obtained by using additional upstream sequences up to -9000 bp (17).
###end p 8
###begin p 9
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 276 279 276 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 439 442 439 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 509 513 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 669 672 669 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 723 731 723 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 738 745 738 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 915 919 915 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
In order to investigate the transcriptional regulation of cdc6 during megakaryoblastic cells endoreplication, we took advantage of the fact that differentiated Esg-expressing HEL cells lose their ability to endoreplicate and to express Cdc6 (11). We have identified potential Esg-binding sites (E2 boxes) in cdc6 upstream region that could be involved in maintaining Cdc6 expression during endoreplication and inhibited by the presence of Esg in HEL cells. We have found in the -4537 to -2800 region upstream cdc6 transcription initiation site three E2 boxes, one of which overlaps a GATA element. This E2 box/GATA site is the most prominent binding site, not only for Esg but also for endogenous proteins. GATA-1 and E2A 'in vitro' and 'in vivo' occupy this site in endoreplicating cells. Transactivation data indicate that this particular sequence may act as an enhancer involved in transcriptional activation of cdc6 promoter only when megakaryocytic differentiation is stimulated. The results presented here suggest that specific transcriptional mechanisms could be involved in the maintenance of Cdc6 expression that occurs during megakaryocytic endoreplication.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Cell culture
###end title 11
###begin p 12
###xml 45 46 45 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c8">8</xref>
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 124 125 124 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 191 193 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;8</sup>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">o</italic>
###xml 252 254 252 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 545 546 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Cells were cultured as described previously (8,11). To induce megakaryocytic or erythrocytic differentiation, 0.15-0.20 x 106 cells per ml were grown for 48 h in the presence or absence of 10-8 M o-tetradecanoylphorbol 13 acetate (TPA; Sigma) or 5 x 10-5 M hemin (Sigma), respectively. For RNA stabilization studies, exponentially growing and TPA-treated cells were cultured for the indicated times in the presence of actinomycin D (5 mug/ml). For proliferation curves, exponentially growing cells were subcultured into 24-well plates (0.20 x 106 cells per ml and well) with or without TPA. The number of viable cells was determined by trypan blue exclusion in a hemocytometer chamber.
###end p 12
###begin title 13
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Megakaryocyte culture and CD41+ cellsimmunoselection
###end title 13
###begin p 14
###xml 138 139 138 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 240 241 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 355 356 355 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 520 525 <span type="species:ncbi:9606">human</span>
Cord blood (CB) mononucleated cell fraction (MNC) was obtained after separation on Ficoll-Hypaque gradients and counted. A total of 5 x 106 cells were used for nuclear extract isolation. CD34+ cells were isolated from MNC (typically, 5 x 107 cells) using an immunomagnetic procedure (MiniMACS, Miltenyi Biotec, Auburn, CA). CB-purified CD34+ cells (5 x 105) were cultured for 12 days in 24-well culture dishes at 50 000 cells/ml in serum-free medium (CellGro, CellGenix, Freiburg, Germany) supplemented with recombinant human thrombopoietin [(TPO); non-pegylated; 50 ng/ml; generously provided by Kirin, Gunma, Japan].
###end p 14
###begin p 15
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
CD41+ cells generated in culture were purified using colloidal magnetic dextran iron particles that were selectively bound to target cells by means of anti-CD41 bi-specific tetrameric antibody complexes (StemSep, StemCell Technologies, Vancouver, BC, Canada). These complexes recognize both dextran and CD41 surface antigen. Labeled cells were retained in a column placed in a magnetic field and after washing, CD41+ cells were eluted from the column, according to the manufacturer's instructions.
###end p 15
###begin title 16
Plasmids and transfection assays
###end title 16
###begin p 17
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c17">17</xref>
###xml 415 418 415 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1061 1062 1061 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1029 1135 1029 1135 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18">To prepare pHscdc6(4537/&#8722;2800) A<sup>M</sup>: 5&#8242;-AGCTGGGACCAAGCTTGTGTACCACT-3&#8242;; and 5&#8242;-AGTGGTACACAAGCTTGGTCCCAGCT-3&#8242;.</p>
###xml 1029 1135 1029 1135 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18">To prepare pHscdc6(4537/&#8722;2800) A<sup>M</sup>: 5&#8242;-AGCTGGGACCAAGCTTGTGTACCACT-3&#8242;; and 5&#8242;-AGTGGTACACAAGCTTGGTCCCAGCT-3&#8242;.</p></list-item>
###xml 1167 1168 1167 1168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1135 1233 1135 1233 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="19">To prepare pHscdc6(4537/&#8722;2800) B<sup>M</sup>: 5&#8242;-GTATGAGTTAGGAGTTGATAAG-3&#8242;; and 5&#8242;-AGGTCCTTATCAACTCCTAACT-3&#8242;.</p>
###xml 1135 1233 1135 1233 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="19">To prepare pHscdc6(4537/&#8722;2800) B<sup>M</sup>: 5&#8242;-GTATGAGTTAGGAGTTGATAAG-3&#8242;; and 5&#8242;-AGGTCCTTATCAACTCCTAACT-3&#8242;.</p></list-item>
###xml 1269 1270 1269 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1233 1335 1233 1335 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="20">To prepare pHscdc6(4537/&#8722;2800) BGATA<sup>M</sup>: 5&#8242;-GTATGAGTTAGCAGGTGCACAG-3&#8242;; and 5&#8242;-AGGTCCTGTGCACCTGCTAACT-3&#8242;.</p>
###xml 1233 1335 1233 1335 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="20">To prepare pHscdc6(4537/&#8722;2800) BGATA<sup>M</sup>: 5&#8242;-GTATGAGTTAGCAGGTGCACAG-3&#8242;; and 5&#8242;-AGGTCCTGTGCACCTGCTAACT-3&#8242;.</p></list-item>
###xml 1367 1368 1367 1368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1335 1441 1335 1441 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21">To prepare pHscdc6(4537/&#8722;2800) C<sup>M</sup>: 5&#8242;-GAGGCTGAGGGGATCCGATCACCTGA-3&#8242;; and 5&#8242;-TCAGGTGATCGGATCCCCTCAGCGTC-3&#8242;.</p>
###xml 1335 1441 1335 1441 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="21">To prepare pHscdc6(4537/&#8722;2800) C<sup>M</sup>: 5&#8242;-GAGGCTGAGGGGATCCGATCACCTGA-3&#8242;; and 5&#8242;-TCAGGTGATCGGATCCCCTCAGCGTC-3&#8242;.</p></list-item>
###xml 1029 1441 1029 1441 <list xmlns:xlink="http://www.w3.org/1999/xlink" list-type="bullet"><list-item><p textid="18">To prepare pHscdc6(4537/&#8722;2800) A<sup>M</sup>: 5&#8242;-AGCTGGGACCAAGCTTGTGTACCACT-3&#8242;; and 5&#8242;-AGTGGTACACAAGCTTGGTCCCAGCT-3&#8242;.</p></list-item><list-item><p textid="19">To prepare pHscdc6(4537/&#8722;2800) B<sup>M</sup>: 5&#8242;-GTATGAGTTAGGAGTTGATAAG-3&#8242;; and 5&#8242;-AGGTCCTTATCAACTCCTAACT-3&#8242;.</p></list-item><list-item><p textid="20">To prepare pHscdc6(4537/&#8722;2800) BGATA<sup>M</sup>: 5&#8242;-GTATGAGTTAGCAGGTGCACAG-3&#8242;; and 5&#8242;-AGGTCCTGTGCACCTGCTAACT-3&#8242;.</p></list-item><list-item><p textid="21">To prepare pHscdc6(4537/&#8722;2800) C<sup>M</sup>: 5&#8242;-GAGGCTGAGGGGATCCGATCACCTGA-3&#8242;; and 5&#8242;-TCAGGTGATCGGATCCCCTCAGCGTC-3&#8242;.</p></list-item></list>
###xml 90 95 <span type="species:ncbi:9606">human</span>
pHscdc6(4537), a reporter plasmid containing a 4.54 kb fragment of the upstream region of human cdc6 gene inserted into pGL2Basic (Promega), was kindly provided by Dr Nakamura (Tokyo Medical and Dental University, Tokyo, Japan) (17). To construct pHscdc6(-2800), a 1.2 kb KpnI/XhoI fragment and 1.64 kb BamHI/KpnI fragment isolated from pHscdc6luc were inserted in between the BamHI and XhoI sites of pBluescript SK+/- (Stratagene). The resulting construct was digested with SacI/XhoI to isolate a 2.9 kb fragment that was ligated in between the SstI and XhoI sites of pGL2Basic. To construct pHscdc6(-1600), 1.6 kb HindIII fragment from pHscdc6Luc was inserted into the HindIII site of pGL2Basic. To construct pHscdc6(4537/-2800), a 1.7 kb KpnI/BamHI fragment from pHscdc6(4537) was inserted in between the KpnI/BglII of pGL2Promoter (Promega). Mutagenesis of the E2 boxes sites was performed in pHscdc6(4537/-2800) using the Quick Change Method (Quick Change kit, Stratagene Corp.) by employing the following oligonucleotides: To prepare pHscdc6(4537/-2800) AM: 5'-AGCTGGGACCAAGCTTGTGTACCACT-3'; and 5'-AGTGGTACACAAGCTTGGTCCCAGCT-3'.To prepare pHscdc6(4537/-2800) BM: 5'-GTATGAGTTAGGAGTTGATAAG-3'; and 5'-AGGTCCTTATCAACTCCTAACT-3'.To prepare pHscdc6(4537/-2800) BGATAM: 5'-GTATGAGTTAGCAGGTGCACAG-3'; and 5'-AGGTCCTGTGCACCTGCTAACT-3'.To prepare pHscdc6(4537/-2800) CM: 5'-GAGGCTGAGGGGATCCGATCACCTGA-3'; and 5'-TCAGGTGATCGGATCCCCTCAGCGTC-3'.
###end p 17
###begin p 18
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
To prepare pHscdc6(4537/-2800) AM: 5'-AGCTGGGACCAAGCTTGTGTACCACT-3'; and 5'-AGTGGTACACAAGCTTGGTCCCAGCT-3'.
###end p 18
###begin p 19
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
To prepare pHscdc6(4537/-2800) BM: 5'-GTATGAGTTAGGAGTTGATAAG-3'; and 5'-AGGTCCTTATCAACTCCTAACT-3'.
###end p 19
###begin p 20
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
To prepare pHscdc6(4537/-2800) BGATAM: 5'-GTATGAGTTAGCAGGTGCACAG-3'; and 5'-AGGTCCTGTGCACCTGCTAACT-3'.
###end p 20
###begin p 21
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
To prepare pHscdc6(4537/-2800) CM: 5'-GAGGCTGAGGGGATCCGATCACCTGA-3'; and 5'-TCAGGTGATCGGATCCCCTCAGCGTC-3'.
###end p 21
###begin p 22
###xml 97 98 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Cells were transfected by electroporation at 975 muF/250 V in a 0.4 cm cuvette. A total of 5 x 106 cells were transfected with 5 mug of the various plasmids and 5 mug of renilla plasmid (Promega). After 5 h, cells were washed with phosphate-buffered saline (PBS), counted and divided into two aliquots one of which was treated with TPA. At the end of 48 h following electroporation, cells were harvested and cell extracts for assaying luciferase activity were prepared using the Dual Luciferase kit (Promega), according to the manufacturer's instructions.
###end p 22
###begin title 23
Northern blot
###end title 23
###begin p 24
###xml 186 190 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 335 337 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 483 487 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 656 660 654 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
Total RNA was extracted using TRIzol(R) Reagent (Life Technologies), following the procedure described by the manufacturer. All other conditions, including the source and preparation of cdc6-specific cDNA probe and the entire pTRI RNA 28S plasmid, which hybridizes to 28S rRNA (Ambion, Inc., Austin, TX), were as described previously (11). The autoradiographs were scanned using a densitometer (GE-800 Calibrated Densitometer; Bio-Rad) to determine the relative optical densities of cdc6 mRNA and 28S rRNA hybridization signals. For each RNA sample, the signal for the transcripts was measured within the linear range of the densitometer, and the ratio of cdc6 mRNA signals to 28S rRNA was calculated.
###end p 24
###begin title 25
Mobility gel shift analysis
###end title 25
###begin p 26
###xml 44 45 44 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c8">8</xref>
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 526 527 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 602 603 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
EMSA were perfomed as described previously (8) with 0.02 pmol of 32P-labelled oligoprobe and 20 mug of nuclear extracts. The partially complementary oligonucleotides are as follows: 5'-GCGGCCTGACAGGTGC-3' and 5'-CAAAGCACCTGTCAGGC-3' (EBE probe); 5'-GCTGGGACCACAGGTGTGTAC-3' and 5'-AGTGGTACACACCTGTGGTCC-3' (BoxA); 5'-GTATGAGTTAGCAGGTGATAAG3' and 5'-AGGTCCTTATCACCTGCTAACT-3' (BoxB); 5'-GAGGCTGAGGCAGGTGGATCAC-3' and 5'- CTCAGGTGATCCACCTGCCTCA-3' (BoxC); 5'-GTATGAGTTAGCAGGTGCACAG-3' and 5'-AGGTCCTGTGCACCTGCTAACT-3' (BoxB GATAM); 5'-GTATGAGTTAGGAGTTGATAAG-3' and 5'-AGGTCCTTATCAACTCCTAACT-3' (BoxB EboxM); 5'-AATTCGCAGGTGACAGGTGGCAGGTGACAGGTGT-3' and 5'-CTAGACACCTGTCACCTGCCACCTGTCACCTGCG-3' (E2 box tandem).
###end p 26
###begin p 27
###xml 197 198 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 252 254 252 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
These were used to generate double-stranded oligoprobes. Binding reactions were carried out for 20 min at room temperature in binding buffer [20% glycerol, 1 mM DTT, 20 mM HEPES (pH 7.9), 5 mM MgCl2, 100 mM KCl and 0.2 mM EDTA] containing 0.02 pmol of 32P-labelled oligoprobe, 20 mug of protein extracts as indicated, and 40 mug/ml poly(dI-dC). When needed, competitor oligoprobes were added in excess to the binding reaction. For supershifts experiments, 2 mul of anti-GATA-1 (C-20 Santa Cruz), anti-GATA-2 (H-116 Santa Cruz), anti-E2A (V-18 Santa Cruz) antibodies were incubated with the nuclear extracts for 2 h at 4degreesC before the addition of the radiolabelled probe. DNA-protein complexes were separated from unbound labelled oligoprobes on 6% non-denaturing polyacrylamide gels in Tris-Borate/EDTA buffer. After drying, the shifted complexes were visualized using autoradiography.
###end p 27
###begin title 28
Western blot
###end title 28
###begin p 29
###xml 159 160 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 428 433 <span type="species:ncbi:9606">human</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 549 553 <span type="species:ncbi:9925">goat</span>
###xml 559 564 <span type="species:ncbi:10090">mouse</span>
###xml 583 594 <span type="species:ncbi:3704">horseradish</span>
Nuclear extracts (30 mug) were subjected to SDS-PAGE and proteins transferred onto BioTrace PVDF membranes (Pall Corporation, Ann Arbor, MI) for 1 h at 2 mA/cm2 on a semidry transfer apparatus (Amersham). Ponceau staining was routinely performed on membranes to check sample loading control. After blocking in PBS containing 0.1% Tween-20 (T-PBS) and 5% skimmed dry milk, filters were incubated overnight at 4degreesC with anti-human Cdc6 mouse mAb (Ab3; Oncogene, Darmstadt, Germany) at a 1:500 dilution in T-PBS. After washing and incubation with goat anti-mouse IgG conjugated to horseradish peroxidase (Dako, Glostrup, Denmark), signals were detected using the enhanced chemiluminescence system (Pierce, Rockford, IL).
###end p 29
###begin title 30
Chromatin immunoprecipitation assays
###end title 30
###begin p 31
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c23">23</xref>
###xml 640 641 633 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 945 1043 913 1011 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">For cdc6 E2 box/GATA site: 5&#8242;-ATTCTGTCTTCTTGTGATGGTATTGC-3&#8242;; and 5&#8242;-GGTCGTTTAGTTCATGGTTAGATTGG-3&#8242;.</p>
###xml 945 1043 913 1011 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32">For cdc6 E2 box/GATA site: 5&#8242;-ATTCTGTCTTCTTGTGATGGTATTGC-3&#8242;; and 5&#8242;-GGTCGTTTAGTTCATGGTTAGATTGG-3&#8242;.</p></list-item>
###xml 1043 1132 1011 1100 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">For cdc6 (&#8722;2000): 5&#8242;-TTGTATTTTAGTAGAGACGGGGTTTC-3&#8242;; and 5&#8242;-GATGGTATTTCTGATGTCTTAGTAGG-3&#8242;.</p>
###xml 1043 1132 1011 1100 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">For cdc6 (&#8722;2000): 5&#8242;-TTGTATTTTAGTAGAGACGGGGTTTC-3&#8242;; and 5&#8242;-GATGGTATTTCTGATGTCTTAGTAGG-3&#8242;.</p></list-item>
###xml 1132 1226 1100 1190 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34">For &#947;-globin site: 5&#8242;-AGAGAAAAACTGGAATGACTGAATCG-3&#8242;; and 5&#8242;-AAGCGAGTGTGTGGAACTGCTGAAGG-3&#8242;.</p>
###xml 1132 1226 1100 1190 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34">For &#947;-globin site: 5&#8242;-AGAGAAAAACTGGAATGACTGAATCG-3&#8242;; and 5&#8242;-AAGCGAGTGTGTGGAACTGCTGAAGG-3&#8242;.</p></list-item>
###xml 945 1226 913 1190 <list xmlns:xlink="http://www.w3.org/1999/xlink" list-type="bullet"><list-item><p textid="32">For cdc6 E2 box/GATA site: 5&#8242;-ATTCTGTCTTCTTGTGATGGTATTGC-3&#8242;; and 5&#8242;-GGTCGTTTAGTTCATGGTTAGATTGG-3&#8242;.</p></list-item><list-item><p textid="33">For cdc6 (&#8722;2000): 5&#8242;-TTGTATTTTAGTAGAGACGGGGTTTC-3&#8242;; and 5&#8242;-GATGGTATTTCTGATGTCTTAGTAGG-3&#8242;.</p></list-item><list-item><p textid="34">For &#947;-globin site: 5&#8242;-AGAGAAAAACTGGAATGACTGAATCG-3&#8242;; and 5&#8242;-AAGCGAGTGTGTGGAACTGCTGAAGG-3&#8242;.</p></list-item></list>
###xml 368 371 <span type="species:ncbi:10116">rat</span>
###xml 389 393 <span type="species:ncbi:9925">goat</span>
###xml 425 431 <span type="species:ncbi:9986">rabbit</span>
The procedure was performed as described previously (23), with the following modifications. Nuclear extracts were sonicated with three cycles of 15 s each at 50% maximum power and 8 mA amplitude with a sonicator (Soniprep 150, MSE), and Protein-G Sepharose (Oncogene Research Products) was used instead of Protein-A Sepharose. Incubation with antibodies (anti-GATA-1, rat monoclonal N6 or goat polyclonal C-20, and anti-E2A, rabbit polyclonal V-18, all from Santa Cruz Biotechnology) or the corresponding non immune isotype immunoglobulins (Sigma) was carried out overnight at 4degreesC. The extracted DNA was resuspended in 30 mul water/107 cells. An aliquot of 5 mul and the equivalent to 1/1000 of the input fraction was used for each PCR (40 cycles of 30 s at 94degreesC; 30 s at 56degreesC; 30 s at 72degreesC and one last cycle of 10 min at 72degreesC), containing 25 pmol of each upper and lower primers. The following primers were used: For cdc6 E2 box/GATA site: 5'-ATTCTGTCTTCTTGTGATGGTATTGC-3'; and 5'-GGTCGTTTAGTTCATGGTTAGATTGG-3'.For cdc6 (-2000): 5'-TTGTATTTTAGTAGAGACGGGGTTTC-3'; and 5'-GATGGTATTTCTGATGTCTTAGTAGG-3'.For gamma-globin site: 5'-AGAGAAAAACTGGAATGACTGAATCG-3'; and 5'-AAGCGAGTGTGTGGAACTGCTGAAGG-3'. PCR products were separated in a 1.5% TBE-agarose gel and DNA was visualized by Ethidium Bromide staining.
###end p 31
###begin p 32
For cdc6 E2 box/GATA site: 5'-ATTCTGTCTTCTTGTGATGGTATTGC-3'; and 5'-GGTCGTTTAGTTCATGGTTAGATTGG-3'.
###end p 32
###begin p 33
For cdc6 (-2000): 5'-TTGTATTTTAGTAGAGACGGGGTTTC-3'; and 5'-GATGGTATTTCTGATGTCTTAGTAGG-3'.
###end p 33
###begin p 34
For gamma-globin site: 5'-AGAGAAAAACTGGAATGACTGAATCG-3'; and 5'-AAGCGAGTGTGTGGAACTGCTGAAGG-3'.
###end p 34
###begin title 35
Flow cytometry determinations
###end title 35
###begin p 36
###xml 168 169 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 180 184 <span type="species:ncbi:9913">calf</span>
###xml 205 210 <span type="species:ncbi:9606">human</span>
Cell surface immunofluorescence staining was performed by incubating cells at room temperature with the appropriate dilution in phosphate-buffered saline (PBS)/0.1% NaN3/10% fetal calf serum (FCS) of anti-human GPIIIa (CD61) fluorescein isothiocyanate (FITC)-conjugated antibody (Becton Dickinson) for 20 min. To determine DNA content, cells were harvested by centrifugation at 500 g for 5 min, washed in ice-cold PBS and then resuspended in PBS containing 50 mug/ml propidium iodide (PI) and 0.1% Nonidet P-40. Determination of CD61 expression and cell cycle analysis were performed using a FACScan analyser using CELLQUEST software (both from Becton Dickinson).
###end p 36
###begin title 37
RESULTS
###end title 37
###begin title 38
Constitutive expression of Escargot determines downregulation of Cdc6 expression at RNA level
###end title 38
###begin p 39
###xml 269 287 269 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D.melanogaster Esg</italic>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 366 369 366 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c8">8</xref>
###xml 477 480 477 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 525 528 525 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 657 660 657 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 727 730 727 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 757 761 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 795 796 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f1">1</xref>
###xml 842 845 842 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 947 950 947 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1019 1023 1019 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1095 1098 1095 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1235 1239 1235 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1259 1262 1259 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1366 1370 1366 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1418 1421 1418 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1569 1570 1545 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f1">1</xref>
###xml 1601 1605 1577 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1842 1843 1818 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f1">1</xref>
###xml 1884 1888 1860 1864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 2115 2119 2091 2095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 2251 2255 2227 2231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 2425 2426 2401 2402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c8">8</xref>
###xml 2439 2440 2415 2416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f1">1</xref>
###xml 2481 2485 2457 2461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 2535 2537 2511 2513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 2550 2551 2526 2527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f1">1</xref>
###xml 269 283 <span type="species:ncbi:7227">D.melanogaster</span>
We have recently shown that cdc6 expression is stabilized during megakaryocytic polyploidization but downregulated in megakaryoblastic cells unable to establish endoreplication cycles, and among them, HA1 cell line, derived from HEL cells by constitutive expression of D.melanogaster Esg (11). We have also shown that ectopic expression of transcriptional repressor Esg in HEL cells inhibits megakaryocytic endomitosis (8). In this paper, HA1 cells have been designated as HEL(Esg+) in order to stress that it is the ectopic Esg expression that differentiates parental and derived cells. Interestingly, Cdc6 protein levels were profoundly diminished in HEL(Esg+) cells, compared to those in parental HEL cells, suggesting that Esg could be interfering with cdc6 gene expression [(11) and Figure 1D]. In an independent search to find putative Esg targets that could be affecting endoreplication, we compared cDNAs of endoreplicating HEL and of HEL(Esg+) cells by DNA microarray hybridization. The analysis revealed that cdc6 was one of the genes significantly downregulated in differentiated HEL(Esg+) (N. Vilaboa and C. Cales, unpublished data). To confirm these data, a northern-blot analysis was carried out to compare the levels of cdc6 RNA in HEL and HEL(Esg+) after TPA treatment, which triggers megakaryocytic differentiation in both cell lines. We found that cdc6 RNA levels were diminished after culturing HEL(Esg+) in the presence of TPA (approximately50%), while a approximately2-fold induction was reached in differentiated endoreplicating HEL cells (Figure 1A). In order to assess whether cdc6 RNA levels increase in TPA-treated HEL cells was due to gene transcription maintained or to RNA stabilization, a similar experiment was performed in the presence of transcription inhibitor actinomycin D (ActD). As can be seen in Figure 1B, as early as 4 h after ActD treatment, cdc6 RNA levels decreased in untreated HEL and HEL(Esg+) cells. Interestingly, in differentiated HEL cells, the increase obtained after TPA treatment was not observed for a long period in the presence of ActD, thus indicating that cdc6 transcription is indeed active during HEL megakaryocytic differentiation. Other possibilities that could account for the different cdc6 RNA levels, i.e. a different proliferation state of parental HEL and Esg-expressing cells, was discarded, as both cell lines stopped proliferating after TPA treatment [(8) and Figure 1C], but only parental HEL cells maintain cdc6 expression at RNA (as shown above) and protein [(11) and Figure 1D) level.
###end p 39
###begin p 40
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
These results also indicate that ectopic expression of Esg is able to interfere with the mechanisms that determine the maintenance of cdc6 expression during megakaryocytic polyploidization.
###end p 40
###begin title 41
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 142 145 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
A 1.7 kb cdc6 5'-upstream region containing putative Esg-binding E2 box motifs is responsible for the reduced cdc6 promoter activation in HEL(Esg+) cells
###end title 41
###begin p 42
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">snail</italic>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c24">24</xref>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 323 326 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f2">2</xref>
Esg belongs to the snail family of zinc finger transcriptional repressors, which function appears to involve binding to E boxes recognized by a variety of basic helix-loop-helix (bHLH) transcriptional activators (24). We thus searched a 4537 bp regulatory cdc6 region for putative sites that could be recognized by ectopic Esg. As shown in Figure 2A, we found three E2 boxes with perfect match to the described Esg consensus-binding site A/GCAGGTG, located at -4501 to -4495 (ACAGGTG), -3535 to -3529 (GCAGGTG) and -2995 to -2989 (GCAGGTG) (referred to as Boxes A, B and C, as indicated). Two other E2 boxes corresponding to much less specific Esg binding sites (C/TCAGGTG or G/ACAGNTG) were detected, at -1567 to -1561 (CCAGGTG) and at -2675 to -2679 (ACAGATG).
###end p 42
###begin p 43
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c17">17</xref>
###xml 462 465 462 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 626 629 626 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 701 702 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f2">2</xref>
###xml 733 737 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 812 815 812 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 834 838 834 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
Transactivation assays were performed by transfecting HEL and HEL(Esg+) cells with a construct containing firefly luciferase gene under the control of -4537 to +98 region of cdc6 upstream region [pHsCdc6-luc(-4537), as in (17)]. As expected, the -4537 to +98 region was able to drive luciferase expression in exponentially growing cells. However, after TPA treatment, luciferase activity was significantly increased in parental HEL but not in differentiated HEL(Esg+) cells. Such activation was only seen after megakaryocytic differentiation, as the addition of hemin resulted in erythroid differentiation of both HEL and HEL(Esg+). This did not result in the induction of luciferase activity (Figure 2B). These results suggest that cdc6 transcriptional activity is induced in endoreplicating HEL cells and that Esg may be modulating cdc6 expression by repressing its promoter activity.
###end p 43
###begin p 44
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 760 764 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
We have previously found that cdc6 RNA levels are also downregulated in megakaryoblastic K562 cells. These cells respond to TPA, as HEL cells do, in terms of megakaryocytic differentiation but lack the ability to establish endoreplication cycles (11). In order to investigate whether increase in cdc6 promoter activity was restricted to endomitotic differentiation, pHsCdc6-luc(-4537) construct was transfected in K562 cells and luciferase activity was determined before and after TPA or hemin treatment. Interestingly, no significant induction of the reporter activity could be detected after erythroid or megakaryocyte differentiation of K562 cells, thus suggesting a relationship between the ability to undergo endoreplication and TPA-driven stimulation of cdc6 promoter activity.
###end p 44
###begin p 45
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f2">2</xref>
###xml 798 802 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
To assess the involvement of Esg-specific E2 boxes on cdc6 transcriptional regulation, a 1.7 kb fragment containing all three sites was deleted and the resulting pHsCdc6-luc(-2800) construct was transfected in HEL, HEL(Esg+) and K562 cells. Luciferase activity was then measured in undifferentiated, TPA- and hemin- treated cell extracts (Figure 2C). While hemin treatment did not result in any induction of luciferase activity, the transcriptional activity of this promoter region was increased at a same extent in all three lines after TPA treatment although no relationship with the ability of the cell to undergo endoreplication could be drawn. Similar results were obtained with pHsCdc6-luc(-1600), a deletion construct containing the E2F-binding elements responsible for cell-cycle-dependent cdc6 expression regulation and lacking the E2 boxes corresponding to much less specific Esg binding sites at -1567 to -1561 and at -2675 to -2679 (data not shown).
###end p 45
###begin p 46
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
These results suggest that the -4537 to -2800 region containing the Esg-specific E2 boxes could be responsible for endoreplication-driven stimulation of cdc6 promoter activity and that Esg could be responsible for its inhibition when overexpressed in HEL cells.
###end p 46
###begin p 47
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 125 128 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 320 323 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f2">2</xref>
###xml 388 392 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 708 711 708 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 918 921 918 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 232 236 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
In order to explore this hypothesis, a 1.7 kb fragment containing -4537 to -2800 of cdc6 5' upstream region (only containing Esg-specific E2 boxes A, B and C), was inserted into a luciferase reporter vector under the control of the SV40 promoter [pHscdc6 (-4537/-2800)]. This fragment was then transfected into HEL, HEL(Esg+) and K562 cells. As seen in Figure 2D, this upstream region of cdc6 gene lacked any detectable transcriptional activity in exponentially growing cells. However, after TPA treatment, this fragment was able to drive luciferase expression in all three lines. Interestingly, the degree of transcriptional activation was much higher in endoreplicating HEL than in non-endoreplicating HEL(Esg+) and K562 cells. Additionally, transcriptional activity of this 1.7 kb fragment was associated with megakaryocytic differentiation only, since no relevant luciferase activity could be detected in HEL, HEL(Esg+) or K562 cells that underwent erythrocytic differentiation in the presence of hemin.
###end p 47
###begin p 48
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
Taken together, these results suggest that cdc6 promoter activity is induced in endoreplicating HEL cells and that Esg-specific E2 boxes located at -4537 to -2800 may be critical for such a transcriptional regulation.
###end p 48
###begin title 49
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
Escargot preferentially binds one of three E2 boxes located in the 5' upstream region of cdc6 gene
###end title 49
###begin p 50
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 102 110 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 125 128 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f3">3</xref>
###xml 657 658 657 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f3">3</xref>
###xml 731 734 731 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 854 855 854 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c8">8</xref>
###xml 858 861 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 880 881 880 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 998 999 998 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f3">3</xref>
###xml 1027 1030 1027 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1101 1102 1101 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f3">3</xref>
###xml 1117 1120 1117 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1295 1298 1295 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1324 1327 1324 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1355 1363 1355 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1412 1416 1412 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1748 1751 1748 1751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1939 1942 1939 1942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1974 1975 1974 1975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f3">3</xref>
We hypothesized whether Esg would bind E2 boxes A, B and C present in -4537 to -2800 enhancer region 'in vitro'. HEL and HEL(Esg+) cells were cultured in the presence or the absence of TPA and collected 48 h later to isolate nuclear extracts. At this time of differentiation, HEL cells were actively undergoing endoreplication cycles, which takes place up to 4 days (Figure 3A) and even up to 1 week (data not shown). Nuclear extracts were then analyzed by electrophoretic mobility shift assays (EMSA) using labeled double-stranded oligonucleotides containing E2 boxes A, B or C, and 9-11 surrounding nucleotides (Box A, Box B and Box C, as shown in Figure 3B). An oligonucleotide containing the consensus ACAGGTG binding site for Esg (hereafter referred to as the Esg Binding Element, EBE) was also included as a positive control. As already described (8), Esg present in HEL(Esg+) nuclear extracts results in a specific pattern of two main, specific shifted bands when complexed with EBE (Figure 3B, lanes 1 and 2). When HEL(Esg+) nuclear extracts were incubated with Box A, Box B and Box C (Figure 3B, lanes 3-8), Esg complexes were prominently observed with Box B but barely detected with Boxes A and C. The pattern of shifted proteins was very similar in control and TPA differentiated HEL(Esg+). Thus, it appears that Esg is able to bind, at least 'in vitro', to one out of three putative binding sites in cdc6 5' upstream region. In addition, two main extra bands (complexes I and II) were detected to bind Box B, but not EBE, suggesting the existence of endogenous nuclear factors that would also bind Box B. To test this, EMSA was then performed with nuclear extracts from parental TPA-untreated and -treated HEL cells. As observed in the Esg-expressing cells, binding to Box B was most prominent than to Boxes A and C, and indeed EBE. More interestingly, complexes I and II were also detected to bind Box B while as expected, no Esg complexes were present (Figure 3D). Thus, it appears that HEL cells contain endogenous factors that also recognize this site.
###end p 50
###begin title 51
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
Endogenous nuclear factors specifically bind the E2 box and an overlapping GATA site at -3535/-3529 of cdc6 promoter
###end title 51
###begin p 52
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 464 465 464 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 474 475 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f4">4</xref>
###xml 678 681 678 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 747 748 747 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f4">4</xref>
###xml 805 806 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 813 814 813 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 851 854 851 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 960 961 960 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1004 1005 1004 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1168 1169 1168 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1406 1407 1406 1407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1441 1442 1441 1442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
As Box B seemed to contain the most preferred DNA binding site for ectopic Esg, as well as for the putative endogenous nuclear factors, we wanted to confirm their binding specificity through competition experiments with unlabeled Box B, using extracts from HEL(Esg+) cells. Examination of Box B sequence revealed the existence of a GATA motif overlapping the described E2 box, which prompted us to perform binding assays on Box B in the presence of unlabeled BEboxM or BGATAM mutated oligonucleotides, as well as with an unrelated oligo containing four E2 boxes in tandem (E2 box tandem) (Figure 4A). First, competition with an excess of unlabeled Box B indicated that not only Esg but also the endogenous complexes I and II were specific (Figure 4B). Second, competition with an excess of unlabeled BEboxM, BGATAM or E2 box tandem revealed that: (i) Esg binds through the E2 box, since it was only competed with the oligos containing a wild-type E2 box (BGATAM and E2 box tandem), but not with the BEboxM; (ii) complex II binds through the GATA motif and does not require the E2 box, as it only competes with the oligo that contains wild-type GATA binding site (BEboxM); (iii) complex I binds through the E2 box, but also requires the surrounding intact GATA motif, since it competes with oligos containing intact E2 boxes (E2 box tandem), but not with the oligos containing either a mutated E2 box (BEboxM) or the mutated GATA motif (BGATAM).
###end p 52
###begin p 53
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 196 197 196 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f4">4</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f4">4</xref>
###xml 465 473 465 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escargot</italic>
###xml 491 494 491 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 547 548 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f4">4</xref>
In order to further characterize the complexes binding requirements, in particular that of complex I, we performed EMSA analysis to determine the binding pattern to mutated oligos BEboxM and BGATAM (Figure 4C and D, respectively). As can be observed, only complex II could bind the oligo containing the mutated E2 box (Figure 4C). This is in agreement with complex II requiring only GATA motif and complex I requiring an intact E2 box, as it was also observed with Escargot. Inversely, only Esg complexes could be detected when labeled oligo BGATAM was used (Figure 4D). Thus, this further strengthened the observation that complex I requires both intact E2 box and GATA motifs to bind to Box B.
###end p 53
###begin p 54
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f4">4</xref>
###xml 330 333 330 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
To further confirm the specificity of endogenous complexes, competition experiments were carried out with nuclear extracts from parental HEL cells, untreated or TPA differentiated. As shown in Figure 4E, the specificity of complexes I and II in both undifferentiated and differentiated cells was identical to that detected in HEL(Esg+) cells.
###end p 54
###begin p 55
These results indicate that at least two endogenous complexes are present in HEL cells before and after TPA treatment: complex I which binds the E2 box, but requires intact adjacent GATA sequence and complex II which specifically binds to and only requires GATA motif.
###end p 55
###begin title 56
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
GATA-1 and E2A proteins bind to the E2 box/GATA site 'in vitro' and 'in vivo'
###end title 56
###begin p 57
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f5">5</xref>
###xml 1103 1104 1103 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f5">5</xref>
In an attempt to identify endogenous factors contained in complexes I and II, we investigated whether individual proteins with specific ability to bind the E2 box/GATA motif were involved in the binding to Box B site. One obvious candidate was GATA-1, since this protein is expressed in megakaryoblastic cells and affects megakaryocytic development. On the other hand, an independent one-hybrid experiment aimed to look for putative endogenous factors that would bind the EBE element allowed us to identify E2A (both E12 and E47) and E2-2 bHLH proteins as endogenous factors recognizing the G/ACAGGTG E2 box (N. V. and C. C., unpublished data). Thus, EMSA analysis was performed using HEL nuclear extracts in the presence or absence of specific antibodies against these proteins. As shown in Figure 5A, complex II faced severe competition in the presence of anti GATA-1 antibody, whereas no effect was detected with an equivalent amount of non-immune serum, or a GATA-2 antibody. Also, pre-incubation with antiE2A antibody, but not with non-immune serum, resulted in downregulation of complex I (Figure 5B).
###end p 57
###begin p 58
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f5">5</xref>
These results suggest that while Esg binds the E2 box motif, E2A bHLH factors could be part of the E2 box binding complex I, dependent on the intact E2 box/GATA sequence of Box B site. On the other hand, GATA-1 containing complex II would bind the GATA motif, as illustrated in Figure 5C.
###end p 58
###begin p 59
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 136 143 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 535 539 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f5">5</xref>
###xml 1089 1091 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c25">25</xref>
###xml 1198 1202 1198 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1336 1337 1336 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f5">5</xref>
###xml 1506 1509 1506 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1526 1527 1526 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f5">5</xref>
Owing to the 'in vitro' nature of EMSA experiments, we hypothesized whether the endogenous proteins were bound to the E2 box/GATA site 'in vivo'. Chromatin Immunoprecipitation (ChIP) experiments were then performed by isolating cross-linked chromatin from HEL nuclear extracts. Both anti-GATA-1 and anti-E2A antibodies, as well as the corresponding non-immune Ig controls, were used to immunoprecipitate the fragmented chromatin and after reversal of the cross-link, PCR was performed to detect the presence of the E2 box/GATA site of cdc6 upstream region. As can be seen in Figure 5D, in both anti-GATA-1 and anti-E2A immunoprecipitated fractions, a 249 bp band corresponding to the expected amplimer for this site could be detected, whereas no amplification was obtained in the non-immune Ig-precipitated fractions. A similar specific presence of site B could be detected with two independent anti-GATA-1 antibodies. Anti-GATA-1, unlike anti-E2A, antibodies were also able to immunoprecipitate a fragment corresponding to a region of gamma-globin promoter, already shown to bind GATA-1 (25). No amplified DNA was obtained when PCR was performed using primers located approximately -2000 upstream cdc6 promoter. Both GATA-1 and E2A binding to B site could also be detected when ChIP was performed in HEL cells treated with TPA (Figure 5E), indicating that both proteins are bound to the endogenous regulatory site in differentiated cells. Similar results were obtained with TPA-treated and -untreated HEL(Esg+) cells (Figure 5E).
###end p 59
###begin p 60
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
These data indicate that GATA-1 and E2A proteins are able to bind the E2 box/GATA site 'in vivo'.
###end p 60
###begin title 61
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
The enhancer activity of -4537 to -2800 cdc6 5' upstream region in megakaryocytic endoreplicating cells is mainly mediated though the E2 box/GATA-binding motif
###end title 61
###begin p 62
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 325 326 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f6">6</xref>
###xml 404 407 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f6">6</xref>
###xml 1058 1059 1058 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
We next hypothesized whether the E2 box overlapping a GATA motif was implicated in HEL endoreplication-driven enhancer activity displayed by the entire 1.7 kb fragment. Mutations at the E2 box as well as at GATA-binding element in site B were then introduced in pHscdc6 (-4537/-2800). The resulting plasmids (BEboxM and BGATAM) as well as the wild-type construct (Figure 6A) were transfected in HEL, HEL(Esg+) and K562 cells and luciferase activation was determined in TPA-treated and -untreated cells. As already observed, TPA treatment of cells transfected with the wild-type construct resulted in upregulation of its reporter activity in all three lines and the degree of transcriptional activation was highest in the endoreplicating HEL (Figure 6B). However, the introduction of mutations in the E2 box or the GATA motifs provoked significant changes in the TPA-promoted reporter activity. Thus, the construct containing the E2 box mutation led to a 50% decrease in TPA-promoted inducibility of the 1.7 kb fragment in HEL cells. Interestingly, when BGATAM construct was transfected, a strong loss of activity was obtained (>80%). It seems therefore that an intact E2 box-GATA motif is required for optimal enhancer activity in endoreplicating HEL cells.
###end p 62
###begin p 63
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 407 408 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 480 481 480 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 499 502 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 640 641 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 675 678 675 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 719 722 719 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 757 760 757 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
As expected from our above findings suggesting that Esg might be interfering with the transcriptional activation through the E2 box, transfection of BEboxM construct in HEL(Esg+) cells resulted in higher TPA induction of reported activity than the observed with the wild-type version. In fact, the transcriptional activation was almost identical to that obtained in HEL cells transfected with the same BEboxM construct. Similar to that observed in HEL cells, transfection of BGATAM construct in HEL(Esg+) cells caused a severe decrease in TPA promoted inducibility when compared to the wild-type fragment. Interestingly, comparison of BGATAM reporter activity in HEL and HEL(Esg+) cells showed the inhibitory effect of Esg, in accordance with the fact that Esg does not bind through the GATA binding site. This further strengthens the idea that the E2 box-GATA motif is mainly responsible for the enhancer activity displayed by pHscdc6 (-4537/-2800) in endoreplicating cells.
###end p 63
###begin p 64
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 136 137 136 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
Additionally, we observed that TPA induced luciferase activity did not suffer any significant modification when the BEboxM and the BGATAM constructs were transfected in non-endoreplicating K562, when compared with the wild-type fragment. This suggests that this site is only functional in HEL cells and that it is related to their ability to undergo endoreplication.
###end p 64
###begin p 65
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
Altogether, these results show that the -4537 to -2800 region of cdc6 upstream region can be considered as an enhancer that activates cdc6 expression in an endoreplication-related manner during megakaryocytic differentiation and that this is mainly mediated by the E2 box/GATA motif.
###end p 65
###begin title 66
GATA-1 displays a distinct binding pattern to the -3535/-3525 E2 box/GATA site, depending on the cells ability to undergo endoreplication
###end title 66
###begin p 67
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c7">7</xref>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f2">2</xref>
###xml 579 580 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 589 590 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 847 851 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1065 1066 1065 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f7">7</xref>
###xml 1089 1090 1089 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f7">7</xref>
###xml 1225 1226 1225 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f4">4</xref>
###xml 1470 1471 1470 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f7">7</xref>
###xml 1626 1627 1626 1627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1777 1778 1777 1778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 2111 2112 2111 2112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 2137 2138 2137 2138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f7">7</xref>
###xml 2313 2314 2313 2314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f7">7</xref>
As mentioned earlier, both HEL and K562 cells respond to TPA in terms of megakaryocytic differentiation, although only HEL cells become polyploid (7). Interestingly, TPA treatment results in downregulation of cdc6 gene expression, at both RNA and protein level, in K562 cells, whereas its expression is maintained in HEL cells (11). Furthermore, the TPA-promoted enhancer activity of the 1.7 kb fragment containing -4537 to -2800 of cdc6 5' upstream region containing the E2 box-GATA site was diminished when compared to HEL cells (see Figure 2D) and was not affected when E2 boxM and GATAM constructs were transfected in K562 cells. We first investigated whether extracts from these cells would bind this motif, as observed for HEL and if so, whether they would present differences in the pattern of proteins able to bind the E2 box/GATA site of cdc6 upstream region when differentiated with TPA treatment. EMSA was then performed on nuclear extracts from K562 cells and, as observed in HEL cells, binding to Box B was most prominent than to Boxes A and C (Figure 7A). As shown in Figure 7B, nuclear extracts from K562 cells treated with TPA for 48 h, showed differences when compared with TPA-treated HEL cells (see Figure 4E, lane 2). Thus, although the pattern of GATA-1 and E2A-containing complexes was present in both undifferentiated and TPA-treated K562 cells, two extra bands (complex III) could only be detected in differentiated K562 cells. As seen in Figure 7B, competition experiments revealed that the specificity of GATA-1 and E2A-containing complexes was identical to that detected in HEL cells. However, BEboxM oligonucleotide was able to compete in the binding of complex III to BEbox. Indeed, complex III remained detectable when an excess of unlabeled BGATAM oligonucleotide was used as competitor, indicating that these faster migrating bands contained a protein whose binding to Box B site occurred through the GATA-binding element. Accordingly, GATA-1 and complex III, but not E2A complex, could be detected when EMSA was performed with TPA-treated K562 nuclear extracts and labeled BEboxM oligonucleotide (Figure 7C). In an attempt to determine whether GATA-1 protein was part of complex III, supershift experiments were performed with TPA-treated K562 nuclear extracts. As seen in Figure 7D, the presence of anti-GATA-1 antibody abolished GATA-1-containing complex, as already described, as well as complex III, suggesting that complex III contained GATA-1 protein.
###end p 67
###begin p 68
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
Altogether, these results indicate that GATA-1 and E2A specifically bind the E2 box/GATA motif present in cdc6 5' upstream region in K562 cells, as it occurs in HEL cells. They also indicate that additional GATA-1 complexes bind to this motif in non-endoreplicating K562 cells after TPA-promoted differentiation, when compared to differentiated, endoreplicating HEL cells.
###end p 68
###begin title 69
The pattern of GATA-1- and E2A-containing complexes that bind the E2 box/GATA site is identical in megakaryoblastic cells and primary megakaryocytes
###end title 69
###begin p 70
###xml 693 696 693 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 718 719 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f8">8</xref>
###xml 255 260 <span type="species:ncbi:9606">human</span>
In order to determine whether the pattern of binding of endogenous nuclear factors to the E2 box/GATA motif is associated with megakaryocytic lineage, EMSA experiments were performed with labeled site B oligonucleotide and nuclear extracts from different human cell lines. It is worth noting that only megakaryoblastic cells showed the same characteristic pattern of shifted proteins. HeLa (epithelial origin) or U937 (promonocytic) did not contain any detectable complex, whereas osteosarcoma-derived U2OS, and embryonic kidney 293 contained endogenous proteins able to bind this oligonucleotide, but the pattern of bound proteins was distinct from that detected in megakaryoblastic HEL, HEL(Esg+) K562 cells (Figure 8A).
###end p 70
###begin p 71
###xml 111 119 111 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f8">8</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f8">8</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f8">8</xref>
###xml 1158 1159 1158 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f8">8</xref>
###xml 1246 1247 1246 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f8">8</xref>
###xml 1757 1758 1757 1758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f8">8</xref>
We finally investigated whether primary megakaryocytes contained endogenous nuclear factors were able to bind 'in vitro' the E2 box/GATA site. Umbilical cord blood CD34+ cells were cultured in the presence of thrombopoietin (Tpo) and the content of megakaryocytes was assessed by flow cytometry analysis of lineage-specific GpIIIa glycoprotein (CD61) expression. Typically, >70% of cultured cells were found to be CD61 positive (Figure 8C, Tpo culture). As can be seen in Figure 8B, only two retarded, specific bands could be detected when nuclear extracts from megakaryocytic-enriched cultured cells were incubated with labeled oligonucleotide B. Megakaryocytes were further purified by immunoselection with anti-GpIIb (CD41) antibodies. As shown in Figure 8C, separation resulted in >90% of CD61 positive, of which a significant 30% corresponded to polyploid cells (DNA content >8N). EMSA was performed with nuclear extracts isolated from CD41+ cells (MK), as well as from the MNCs from which they are derived, and that contain blood cells mainly (>90% lymphocytes and monocytes). The pattern of complexes bound to oligonucleotide B in MK extracts (Figure 8D, lanes 1 and 2) was identical to that found in the corresponding Tpo culture (Figure 8B), and also to that detected in megakayoblastic HEL cell line (lanes 7 and 8). No retarded bands were detected in non-megakaryocytic MNC cells (lane 3). Addition of anti-GATA-1 (lane 5) and anti-E2A (lane 10) antibodies to nuclear extracts from megakaryocytic-enriched cultured cells was able to abolish the formation of complexes II and I, respectively, indicating that these complexes contained E2A and GATA-1. Interestingly, Cdc6 was present in the terminally differentiated primary megakaryocytes (Figure 8E).
###end p 71
###begin p 72
Taken together, these results indicate that the binding of E2A and GATA-1 containing complexes to the E2 box/GATA motif is a characteristic of the megakaryocytic lineage.
###end p 72
###begin title 73
DISCUSSION
###end title 73
###begin p 74
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 386 389 386 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 461 467 461 467 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TGATAA</underline>
###xml 552 560 552 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 567 574 567 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 809 817 809 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 703 708 <span type="species:ncbi:9606">human</span>
The data presented in this work indicate that a 1.7 kb fragment located at -4537 to -2800 bp upstream cdc6 gene is a transcription enhancer active in megakaryocytic but not in erythrocytic differentiated cells nor in exponentially growing cells. We have found that the stimulation of cdc6 promoter activity during megakaryocytic endoreplication is dependent on the integrity of a novel cis-regulatory element defined by an E2 box overlapping a GATA motif (GCAGGTGATAA) located at -3535/-3525. Our data also show evidence that this motif is recognized 'in vitro' and 'in vivo' by GATA-1 and E2A containing complexes that bind the E2 box/GATA site in a specific manner. Finally, our data indicate that in human primary megakaryocytes, GATA-1 and E2A transcription factors are able to bind this motif, at least 'in vitro', with identical pattern to that detected in megakaryoblastic cell lines.
###end p 74
###begin p 75
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c11">11</xref>
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c8">8</xref>
###xml 777 780 777 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 885 888 885 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 939 943 939 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1304 1306 1304 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c26">26</xref>
###xml 1309 1312 1309 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1397 1398 1397 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c8">8</xref>
###xml 1414 1417 1414 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1544 1548 1544 1548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1581 1584 1581 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 608 613 <span type="species:ncbi:10090">mouse</span>
###xml 1140 1145 <span type="species:ncbi:10090">mouse</span>
The E2 box/GATA motif in cdc6 upstream region appears to be critical for the endoreplication-related stimulation of the promoter activity. First, when either the E2 box or the GATA elements are mutated, the transcriptional activity of the entire 1.7 kb region is severely impaired. Second, ectopic expression of transcriptional repressor Esg, which specifically binds the E2 box element of the E2 box/GATA motif, leads to a significant inhibition of the enhancer activity in HEL cells. This parallels the loss of Cdc6 expression (11) and of endoreplication ability (8). Interestingly, ectopically expressing mouse Snail HEL cells, which also have lost the ability to undergo endomitosis, show identical pattern of binding of nuclear complexes to the E2 box/GATA motif than HEL(Esg+) cells (N. Vilaboa, R. Bermejo and C. Cales, unpublished data). To our view, it is highly relevant for Esg to interfere with the transcriptional activity of cdc6 gene in differentiated HEL cells, especially as such inhibitory effect seems to affect the endogenous gene transcription as well as an exogenous, reporter gene. It has recently been reported that mouse Sna can attenuate the cell cycle in epithelial MDCK cells, as well as in early embryo development, through partial repression of cyclin D2 promoter activity (26). Esg does not affect cell cycle progression in proliferating megakaryoblastic HEL cells (8). In contrast, Esg inhibition of megakaryocytic endoreplication seems to be related to its ability to interfere with transcriptional activity of cdc6 promoter in differentiated HEL (Esg+) cells.
###end p 75
###begin p 76
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c27">27</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c28">28</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c29">29</xref>
###xml 462 464 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c28">28</xref>
###xml 471 474 447 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 514 518 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 996 999 972 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1111 1115 1087 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1300 1301 1276 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh981f9">9</xref>
###xml 1105 1110 <span type="species:ncbi:10090">mouse</span>
###xml 1282 1285 <span type="species:ncbi:10116">rat</span>
###xml 1445 1450 <span type="species:ncbi:9606">human</span>
It has already been described that a CAGGTG E2 box and a GATA site define a composite, bipartite regulatory element involved in the regulation of a number of erythrocytic and megakaryocytic specific promoters (27,28) including GATA-1 gene itself (29). The formation of a multimeric complex formed by GATA-1, Tal1, E47, Lmo2 and Ldb1A seems to rely on a specific spacing of approximately8-10 bp (approximately1 helix turn) between the E2 box and the GATA motifs (28). The cis-acting element we have found to direct cdc6 transcription during megakaryocytic endoreplication appears to be somehow distinct from that found in promoters of lineage specific genes. Notably, there is no spacing between the E2 box and GATA motifs, and in fact they overlap each other. To our knowledge, this is the first time that this type of E2 box/GATA site is reported and that a differentiation-related role in transcriptional control of a licensing factor involved in polyploidization regulation assigned to such a cis-regulatory element. It is also highly relevant that an identical E2 box/GATA motif was also found in the mouse cdc6 gene locus, although in the 3' untranslated end of the gene instead of the upstream region, and a similar E box/GATA motif in a similar position of the 5' end of the rat locus (Figure 9). This suggests that similar mechanisms may be acting in rodent megakaryocytic polyploidization. The E2box/GATA element is also present in the human GATA-1 locus at chromosome X (N. V., R. B. and C. C., unpublished data). This last observation might be indicative of an additional lineage-specific regulation of GATA-1 expression during megakaryocytic maturation.
###end p 76
###begin p 77
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c30">30</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c32">32</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c33">33</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c34">34</xref>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c35">35</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c35">35</xref>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c36">36</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c37">37</xref>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c38">38</xref>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c39">39</xref>
###xml 1009 1011 1009 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c41">41</xref>
###xml 1131 1135 1131 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1425 1427 1425 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c29">29</xref>
###xml 1615 1617 1615 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c42">42</xref>
###xml 1663 1671 1663 1671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
This paper provides the first evidence that E2A and GATA-1 containing complexes, individually or in coordination, could be regulating cdc6 expression. While both GATA-1 and E2A have been proposed to affect cell cycle control (30-32), to date only E2A has been described to directly affect the expression of cdk inhibitors, such as p21, p15 and p16 (33,34). That cdc6 expression might be specifically controlled during megakaryocytic endoreplication by a lineage-specific transcriptional regulator, such as GATA-1 is reinforced by the earlier proposed implication of this transcription factor in determining proper megakaryocytic polyploidization (35). For instance, GATA-1 deficient megakaryocytes do not undergo endomitosis and show evidence of retarded nuclear maturation (35,36). Moreover, X-linked macrothrombocytopenia is due to various mutations resulting in GATA-1 lack-of-function and an increased number of dysplastic micromegakaryocytes (37,38). Micromegakaryocytes are hypoploid megakaryocytes (39-41), most probably unable to undergo endoreplication cycles. Disruption of the GATA binding motif strongly diminished the cdc6 promoter activity in endoreplicating cells while mutation of the E2 box decreased it to a lesser extent. This is in accordance to the reported predominant importance of the GATA site compared to the E2 box present in the composite E-box-10 bp GATA element 3.7 kb upstream GATA-1 promoter (29). Also, in a non-megakaryocytic cell type, a transcriptional complex between GATA-4 and a bHLH factor (dHAND) requires the GATA site to be intact, whereas the E-box motif is dispensable (42). Finally, it is also worth noting that the 'in vitro' binding of E2A-containing complex to the E2 box/GATA motif requires an intact GATA site, especially when it would be expected that the binding of a bHLH protein took place exclusively through the E2 box element.
###end p 77
###begin p 78
###xml 105 113 105 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh981c43">43</xref>
One interesting result of this paper is the fact that GATA-1 complexes bound to the E2 box/GATA-1 motif 'in vitro' show significant differences between endoreplicating and non-endoreplicating differentiated megakaryocytic cells. In particular, a faster migrating GATA complex is detected in non-endoreplicating differentiated K562 cells. The enhancer activity of the E2 box/GATA motif-containing region is highly reduced in these cells. Certainly, it will be of great interest to investigate whether GATA-1 forms multimeric complexes with other proteins during megakaryocytic differentiation and whether the composition of the complexes and/or post-translational modifications of GATA-1 are different depending on the cell ability to endoreplicate. GATA-1 has been shown to form multimeric complexes with a variety of other transcription factors (i.e. FOG, EKLF, LMO2, SP1, CBP and Fli-1) and the resulting complexes can even display stimulatory or repressive transcriptional activity (43).
###end p 78
###begin p 79
###xml 120 128 120 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 243 251 243 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 377 382 <span type="species:ncbi:9606">human</span>
We have found that human cell lines of different lineages contain endogenous factors able to bind this motif, at least 'in vitro', and that the resulting complex patterns are distinct of those found in megakaryoblastic cells. Noteworthy, our 'in vitro' experiments indicate that GATA-1 and E2A-containing complexes are able to bind to the E2 box/GATA motif present in cultured human primary megakaryocytes, reinforcing the hypothesis that cdc6 promoter activity could be regulated by differentiation-related transcription factors such as E2A and GATA-1.
###end p 79
###begin title 80
Figures and Tables
###end title 80
###begin p 81
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 71 72 71 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 162 164 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;8</sup>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 427 428 427 428 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 577 578 576 577 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 592 595 591 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 840 841 839 840 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
cdc6 mRNA levels are downregulated in differentiated HEL(Esg+) cells. (A) HEL and HEL(Esg+) were cultured for 48 h in the absence (-) or in the presence (+) of 10-8 M TPA for 48 h. Total RNA was extracted and analyzed by northern blotting with full-length cdc6 and 28S rRNA-specific cDNA probes. Quantification of cdc6 mRNA signals normalized by 28S RNA is also shown (dark bars, 3.3 kb specie and light bars, 2.5 kb specie). (B) Cells were cultured as in (A), and then treated for the indicated times with 5 mug/ml Act D. RNA extraction and analysis was performed as in (A). (C) HEL and HEL(Esg+) cells were seeded in triplicate wells and cultured in the absence (closed circles) or in the presence (open triangles) of TPA. At the indicated times, cells were harvested and viable cells were counted as presented in Materials and Methods. (D) Cells were cultured as in (A) and nuclear extracts were isolated, subjected to SDS-PAGE and analyzed by western blotting with anti-Cdc6 antibody. A portion of total protein staining of transferred gel is shown as a loading control.
###end p 81
###begin p 82
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 535 536 535 536 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 541 542 541 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 553 556 553 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 759 760 759 760 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 771 774 771 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 152 157 <span type="species:ncbi:9606">human</span>
cdc6 upstream region containing Esg-binding E2 boxes is responsible for reduced cdc6 expression in non-endoreplicating cells. (A) Scaled diagram of the human cdc6 gene showing the E2 boxes with perfect match to Esg consensus binding sites (referred to as Esg-specific E2 Boxes A, B and C) and E2 boxes corresponding to much less specific Esg binding sites and E2F-binding elements. The arrow indicates the transcription initiation site. Relevant restriction sites are also shown: X, XhoI; B, BamHI; H, HinDIII; K, KpnI; and B, BglII. (B and C) HEL, HEL(Esg+) and K562cells were transfected with pHscdc6(-4537) (B) or pHscdc6(-2800) (C), cultured in the absence or in the presence of TPA or hemin, as indicated, collected and assayed for luciferase activity. (D) HEL, HEL(Esg+) and K562 and cells were transfected with pHscdc6 (-4537/-2800), cultured in the absence or in the presence of TPA or hemin, as indicated, collected and assayed for luciferase activity. The data represent the mean +/- SD of at least three independent experiments.
###end p 82
###begin p 83
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 112 113 112 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 127 130 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 194 196 194 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;8</sup>
###xml 455 456 455 456 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 551 552 551 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 589 592 589 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 740 741 740 741 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
Esg and endogenous factors preferentially bind the E2 box/GATA site located at -3535/-3525 upstream cdc6 gene. (A) HEL and HEL(Esg+) were cultured in the absence (-) or in the presence (+) of 10-8 M TPA for 48 or 96 h as indicated. DNA content pattern of these cells is shown as analyzed by flow cytometry. Vertical axis, relative number of cells; horizontal axis, relative red fluorescence (FL2) in a logarithmic scale, indicating DNA content per cell. (B) Synthetic oligonucleotides corresponding to the EBE, Box A, Box B and Box C used for EMSAs. (C) Nuclear extracts obtained from HEL(Esg+) cells cultured in the absence (-) or in the presence (+) of TPA were incubated with labeled EBE, Box A, Box B or Box C and analyzed using EMSA. (D) Nuclear extracts obtained from HEL cells cultured in the absence (-) or in the presence (+) of TPA were incubated with labeled EBE, Box A, Box B or Box C and analyzed using EMSA. Arrows indicate I, II and Esg complexes, as well a non-specific complex (ns).
###end p 83
###begin p 84
###xml 107 108 107 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 171 172 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 437 438 437 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 466 469 466 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 598 599 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 607 608 607 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 621 622 621 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 630 631 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 708 709 708 709 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 714 715 714 715 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 807 808 807 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 826 827 826 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 915 916 915 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 930 931 930 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1109 1110 1109 1110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1349 1350 1349 1350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1380 1381 1380 1381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 1474 1477 1474 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 1521 1522 1521 1522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
 Endogenous nuclear factors require both E2 box and GATA motifs to bind the -3535/-3525 E2 box/GATA site. (A) Synthetic oligonucleotides corresponding to Box B, Box B EboxM, Box B GATAM and the E2 box tandem used for EMSAs. E2 box appears in boldface and GATA site is boxed. Asterisks show nucleotide modified to obtain mutant E2 box and GATA elements. Esg-specific E2 boxes are marked with a line on the E2 box tandem oligonucleotide. (B) Nuclear extracts from HEL(Esg+) cells were incubated with labeled Box B in the absence (None) or the presence of an excess of unlabelled Box B (B), Box B EboxM (B EboxM), Box B GATAM (B GATAM) or E2 box tandem (25 and 50 times, as indicated) and analyzed using EMSA. (C and D) Binding reactions were carried out with the following labeled oligonucleotides: Box B EboxM (C) or Box B GATAM (D) in the absence (-) or the presence of 50-fold excess of unlabeled Box B, Box B EboxM or Box B GATAM. A reaction containing labeled Box B is shown in the first lane of both (C) and (D) as a control. Arrows indicate I, II and Esg complexes, as well a non-specific complex (ns). (E) Nuclear extracts from HEL cells cultured in the absence (-) or in the presence (+) of TPA were incubated with labeled Box B in the absence (None, lanes 1 and 2) or the presence of 50-fold excess of unlabeled Box B (lanes 3-4), Box B EboxM (lanes 5 and 6) or Box B GATAM (lanes 8 and 9) and analyzed using EMSA. For comparison purposes, nuclear extracts from HEL(Esg+) cells were incubated with labeled Box B (*, lane 7).
###end p 84
###begin p 85
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 93 94 93 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 394 395 386 387 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 561 562 549 550 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 638 646 626 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escargot</italic>
###xml 680 681 668 669 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1102 1106 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 1318 1319 1290 1291 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1405 1408 1377 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 212 216 <span type="species:ncbi:9925">goat</span>
###xml 264 268 <span type="species:ncbi:9925">goat</span>
###xml 276 280 <span type="species:ncbi:9925">Goat</span>
###xml 286 292 <span type="species:ncbi:9986">rabbit</span>
###xml 342 348 <span type="species:ncbi:9986">rabbit</span>
###xml 356 362 <span type="species:ncbi:9986">Rabbit</span>
###xml 451 457 <span type="species:ncbi:9986">rabbit</span>
###xml 502 508 <span type="species:ncbi:9986">rabbit</span>
###xml 516 522 <span type="species:ncbi:9986">Rabbit</span>
###xml 799 803 <span type="species:ncbi:9925">Goat</span>
###xml 812 815 <span type="species:ncbi:10116">Rat</span>
###xml 1490 1494 <span type="species:ncbi:9925">goat</span>
###xml 1498 1504 <span type="species:ncbi:9986">rabbit</span>
###xml 1514 1518 <span type="species:ncbi:9925">goat</span>
###xml 1544 1550 <span type="species:ncbi:9986">rabbit</span>
 Endogenous GATA-1 and E2A bind the -3535/-3525 E2 box/GATA site both in vitro and in vivo. (A) Nuclear extracts from HEL(Esg+) cells were incubated with labeled Box B in the absence (None) or in the presence of goat anti-GATA-1 antibody (alpha-GATA1), non-immune goat serum (Goat NI), rabbit anti-GATA-2 antibody (alpha-GATA2) or non-immune rabbit serum (Rabbit NI), and analyzed using EMSA. (B) A similar experiment was performed in the presence of rabbit anti-E2A antibody (alpha-E2A) or non-immune rabbit serum (Rabbit NI). Arrows show complexes I and II. (C) Schematic representation of the binding requirements of GATA1, E2 box and Escargot complexes to E2 box/GATA motif. (D) ChIP assay was performed using fragmented cross-linked chromatin from HEL cells and anti-GATA-1 antibodies, alphaG (Goat C20, or Rat N6), anti-E2A antibody, alphaE (RabbitV18) or the corresponding non-immune immunoglobulins, NI. One-sixth of total purified DNA was amplified by PCR with primers specific for the fragment including the E2 box-GATA site (Cdc6 E2 box/GATA) as well as an unrelated fragment (Cdc6-2000) of cdc6 upstream region. A fragment in the A-gamma-globin locus (gamma-globin), is included as a positive control. PCRs were also performed using the fragmented chromatin purified prior to antibody incubation (Input). (E) ChIP assays were performed using fragmented cross-linked chromatin from HEL and HEL(Esg+) cells cultured in the absence (-) or in the presence (+) of TPA and non-immune goat or rabbit Ig (NI), goat anti-GATA-1 (alpha-G) or rabbit anti-E2A antibodies (alpha-E).
###end p 85
###begin p 86
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 152 153 152 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 249 250 249 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
 Enhancer activity of -4537 to -2800 cdc6 5' upstream region in megakaryocytic endoreplicating cells is mainly mediated through the E2 box/GATA motif. (A) Diagrams of pHscdc6(-4537/-2800) (wt) and Ebox (BEboxM) and GATA (BGATAM) mutant constructs. (B) HEL, HEL(Esg+) and K562 cells were transfected with wild-type or mutant constructs. Transfected cells were cultured in the absence (-) or in the presence (+) of TPA, collected and assayed for luciferase activity. The data represent the mean +/- SD of at least three independent experiments.
###end p 86
###begin p 87
###xml 115 116 115 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 272 273 272 273 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 520 521 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 551 552 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 645 648 645 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 692 693 692 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 705 706 705 706 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 837 838 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">M</sup>
###xml 874 875 874 875 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 997 1001 <span type="species:ncbi:9925">goat</span>
###xml 1051 1055 <span type="species:ncbi:9925">goat</span>
 Non-endoreplicating K562 cells show additional GATA-1-containing complexes after megakaryocytic differentiation. (A) Nuclear extracts obtained from exponentially growing K562 cells were incubated with labeled Box A, Box B or Box C oligonucleotides and analyzed by EMSA. (B) Nuclear extracts from K562 cells cultured in the absence (-) or in the presence (+) of TPA were incubated with labeled Box B in the absence (None, lanes 1 and 2) or in the presence of 50-fold excess of unlabeled Box B (lanes 3 and 4), Box B EboxM (lanes 5 and 6) or Box B GATAM (lanes 8 and 9) and analyzed using EMSA. For comparison purposes, nuclear extracts from HEL(Esg+) cells were incubated with labeled Box B (*, lane 7). (C) Nuclear extracts from K562 cells cultured in the absence (-) or in the presence (+) of TPA were incubated with labeled Box B EboxM or Box B and analyzed using EMSA. (D) Nuclear extracts from TPA-treated K562 cells were incubated with labeled Box B in the absence (None) or the presence of goat anti-GATA-1 antibody (alpha-GATA1) or non-immune goat serum (NI) and analyzed using EMSA. Arrows indicate the already described E2A and GATA-1 containing complexes, as well as GATA-1-containing complex III.
###end p 87
###begin p 88
###xml 76 77 76 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg</italic>
###xml 304 305 304 305 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 531 532 531 532 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 888 889 888 889 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1351 1352 1343 1344 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 361 366 <span type="species:ncbi:9606">human</span>
###xml 552 557 <span type="species:ncbi:9606">human</span>
 GATA-1 and E2A containing complexes are characteristic of megakaryocytes. (A) Nuclear extracts from exponentially growing HEL, K562, HEL(Esg+), HeLa, 293 U937 and U2OS cells were incubated with labeled Box B oligonucleotide and analyzed using EMSA. Arrows indicate E2A and GATA-1 containing complexes. (B) Nuclear extracts from megakaryocytic-enriched primary human cells (Tpo culture) were incubated with labeled Box B in the absence (None) or the presence (50x) of a 50-times excess of unlabeled Box B and analyzed using EMSA. (C) MNC isolated from human Umbilical Cord Blood, megakaryocytic-enriched cells obtained after culture of MNC-derived CD34+ cells in the presence of Tpo (Tpo-culture) and immuno-selected megakaryocytes (CD41+) were labeled with FITC-conjugated anti-GpIIIa (CD61) antibodies (upper panel) or Propidium Iodide (lower panel) and analyzed using flow cytometry. (D) Nuclear Extracts from CD41+ cells (MK), MNC and HEL cells untreated (control) or TPA-treated (+TPA), were incubated with labeled Box B and analyzed using EMSA. Lane 2: labeling reaction was performed with MK extracts in the presence of 50 times excess unlabeled Box B. Lanes 4-6 and 9-11: labelling reaction was performed with MK extracts in the absence (None) or the presence of non-inmune serum (NI) or the indicated antibodies (alpha-GATA-1 or alpha-E2A). (E) Nuclear extracts were obtained from CD41+ and untreated or TPA-treated HEL cells. Proteins were subjected to SDS-PAGE and analyzed by western blotting with anti-cdc6 antibody. A portion of total protein staining of transferred gel is shown as a loading control.
###end p 88
###begin p 89
###xml 64 73 64 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico</italic>
###xml 261 265 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 59 62 <span type="species:ncbi:10116">rat</span>
###xml 155 158 <span type="species:ncbi:10116">rat</span>
###xml 203 208 <span type="species:ncbi:10090">mouse</span>
###xml 327 332 <span type="species:ncbi:9606">human</span>
###xml 337 340 <span type="species:ncbi:10116">rat</span>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
 A Ebox-GATA element is present in cdc6 locus of mouse and rat. In silico search for the presence of an E2box-GATA motif through approximately50 000 bp of rat chromosome10 (87 675 000-87 725 000 bp) and mouse chromosome 1 (98 530 000-98 610 000 bp) which spans cdc6 gene and surrounding upstream and downstream 15 000 bp. Both human and rat elements are located upstream first exon, whereas mouse element lies in the 3'-untranslated region. Numbers refer to the positions respective to reported first exon.
###end p 89
###begin title 90
ACKNOWLEDGEMENTS
###end title 90
###begin p 91
We acknowledge Dr Nakamura for the generous gift of pHscdc6 construct. We also thank Dr Aurora Sanchez Pacheco for help with ChIP experiments setting and Dr Miguel Vidal for helpful discussions. This work was supported by grants PM98-0046 from the Spanish Ministry of Science and Technology, CAM 08.3/0037/2001 from the 'Comunidad Autonoma de Madrid' and FIS 01/0090-02 from 'Fondo de Investigaciones Sanitarias' to C.C. N.V. was partly supported by a Postdoctoral Fellowship from 'Comunidad Autonoma de Madrid' (Spain).
###end p 91
###begin title 92
REFERENCES
###end title 92

